Rare diseases
Investigational molecules
Locations
Back to Hungary123 clinical trials in Szolnok, Hungary. Every trial is listed in the EU Clinical Trials Register and updated daily.
Study of inclisiran to prevent heart attacks and strokes in people with atherosclerotic cardiovascular disease
HungaryStudy of Pembrolizumab and Axitinib Combination Versus Sunitinib for Patients with Advanced or Metastatic Kidney Cancer
HungaryStudy on the Effectiveness and Safety of JNJ-77242113 for Treating Moderate to Severe Plaque Psoriasis in Adults
HungaryStudy on Long-Term Safety and Efficacy of Amlitelimab for Patients with Moderate to Severe Atopic Dermatitis from Previous Trials
HungaryStudy on Milvexian and Apixaban for Preventing Stroke in Patients with Atrial Fibrillation
HungaryStudy on the Effectiveness and Safety of DC-806 for Adults with Moderate to Severe Plaque Psoriasis
HungaryWeight loss in adults with obesity (with or without type 2 diabetes) using cagrilintide and semaglutide: a study of two dose levels versus semaglutide alone
HungaryComparison of CHF5993 (glycopyrronium bromide, formoterol fumarate dihydrate, and beclometasone dipropionate) and a drug combination for patients with mild to moderate asthma
HungaryEvaluation of Pembrolizumab, Patritumab Deruxtecan, and Drug Combinations in Stage IV Non-Small Cell Lung Cancer: A Phase 2 Umbrella Study
HungaryStudy of Rocatinlimab with Topical Treatments for Adults with Moderate to Severe Atopic Dermatitis
HungaryStudy of bemarituzumab treatment for patients with solid tumors that have high levels of FGFR2b protein
HungaryStudy comparing RO7795081 and semaglutide with placebo in adults with type 2 diabetes mellitus
HungaryThe busiest research cities in the country
What the registry says about research in the country
Extensive clinical trials focusing on plaque psoriasis and atopic dermatitis treatments, evaluating novel therapies for moderate to severe cases.
Multiple trials testing new biological treatments and long-term safety assessments for chronic skin conditions.
Comprehensive research into various cancer types, with particular focus on lung cancer treatments and innovative immunotherapy approaches.
Investigation of novel combination therapies and targeted treatments for advanced stage cancers.
Studies examining treatments for heart failure prevention and management of cardiovascular conditions.
Innovative approaches to reducing cardiovascular risks and improving patient outcomes.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
